FrancophonIA/ELRC3.0 huggingface dataset:
English: Switching from TREVICTA to 1-monthly paliperidone palmitate injectable For switching from TREVICTA to 1-monthly paliperidone palmitate injectable, 1-monthly paliperidone palmitate injectable should be administered at the time the next TREVICTA dose was to be administered using a 3.5-fold lower dose shown in the following table.
Slovenian: Prehod z zdravila TREVICTA na 1-mesečne injekcije paliperidonijevega palmitata Kadar preidemo z zdravila TREVICTA na 1-mesečne injekcije paliperidonijevega palmitata, bolniku uvedemo 1-mesečno injekcijo paliperidonijevega palmitata ob naslednjem načrtovanem injiciranju zdravila TREVICTA, v odmerku, ki je 3,5-krat manjši od odmerka zdravila TREVICTA, kar je prikazano v spodnji preglednici.
English: The contents of the pre-filled syringe should be inspected visually for foreign matter and discolouration prior to administration.
Slovenian: Vsebino napolnjene injekcijske brizge je treba pred odmerjanjem pregledati glede vsebnosti tujkov in spremembe barve.
English: Renal and urinary disorders urinary incontinence, pollakiuria, dysuria urinary retention
Slovenian: Bolezni sečil inkontinenca urina, polakisurija, disurija zastoj urina
English: If administering a Gluteal injection
Slovenian: Injiciranje v glutealno mišico
English: If the last dose of TREVICTA was
Slovenian: Zadnji odmerek zdravila TREVICTA
English: No embryotoxicity or malformations were observed following intramuscular administration of paliperidone palmitate to pregnant rats up to the highest dose (160 mg/kg/day) corresponding to 2.2 times the exposure level in humans at the maximum recommended dose of 525 mg. Other dopamine antagonists, when administered to pregnant animals, have caused negative effects on learning and motor development in the offspring.
Slovenian: Po intramuskularnem injiciranju paliperidonijevega palmitata brejim podganam, pri čemer je bil največji odmerek 160 mg/kg/dan, kar ustreza 2,2-kratni izpostavljenosti pri največjem priporočenem odmerku 525 mg pri človeku, niso opažali toksičnosti za zarodek ali malformacij.
English: Thus, the TREVICTA treatment group was non-inferior to 1-monthly paliperidone palmitate injectable.
Slovenian: Zdravljenje z zdravilom TREVICTA je bilo torej neinferiorno v primerjavi z zdravljenjem z 1-mesečnimi injekcijami paliperidonijevega palmitata.
English: Elderly Your doctor will determine your dose of this medicine if your kidney function is reduced.
Slovenian: Starejši Če imate zmanjšano ledvično funkcijo, vam bo ustrezen odmerek zdravila določil zdravnik.
English: A switch from gluteal to deltoid (and vice versa) should be considered for future injection in the event of injection site discomfort (see section 4.8).
Slovenian: Če se na mestu injiciranja pojavi bolečina, je treba za nadaljnje injekcije pretehtati možnost prehoda z glutealne na deltoidno mišico (in obratno) (glejte poglavje 4.8).
English: There is no equivalent dose of TREVICTA for the 25 mg dose of 1-monthly paliperidone palmitate injectable which was not studied.
Slovenian: Za 1-mesečne injekcije paliperidonijevega palmitata v odmerku 25 mg ni ustreznega odmerka zdravila TREVICTA in ga tudi niso preučevali.
English: It is important to shake the syringe vigorously with the tip up and a loose wrist for at least 15 seconds to ensure a homogeneous suspension.
Slovenian: Pomembno je, da injekcijsko brizgo, z vrhom obrnjenim navzgor, najmanj 15 sekund močno stresate z gibi iz zapestja, da postane suspenzija homogena.
English: Although in vitro studies suggested a role for CYP2D6 and CYP3A4 in the metabolism of paliperidone, there is no evidence in vivo that these isozymes play a significant role in the metabolism of paliperidone.
Slovenian: Čeprav študije in vitro kažejo, da pri presnovi paliperidona sodelujeta tudi encima CYP2D6 in CYP3A4, in vivo ni dokazov, da bi imela ta dva izoencima pomembno vlogo pri presnovi paliperidona.
English: • shortness of breath, congestion of breathing passages, wheezing, sore throat, nosebleeds
Slovenian: • zadihanost, zapora dihalnih poti, piskajoče dihanje, vneto grlo, krvavitev iz nosu
English: There were no potentially prolactin related adverse reactions among males in either group.
Slovenian: Tudi pri moških niso v nobeni od skupin opazili nobenega neželenega učinka, ki bi bil lahko povezan s prolaktinom.
English: tremor, headache tardive dyskinesia, syncope, psychomotor hyperactivity, dizziness postural, disturbance in attention, dysarthria, dysgeusia, hypoaesthesia, paraesthesia neuroleptic malignant syndrome, cerebral ischaemia, unresponsive to stimuli, loss of consciousness, depressed level of consciousness, convulsion e, balance disorder, coordination abnormal,
Slovenian: glavobol tardivna diskinezija, sinkopa, psihomotorična hiperaktivnost, posturalna omotica, motnje pozornosti, disartrija, disgevzija, hipestezija, parestezija nevroleptični maligni sindrom, možganska ishemija, neodzivnost na dražljaje, izguba zavesti, zmanjšana stopnja zavesti, konvulzije e, motnje ravnotežja, motnje v koordinaciji diabetična koma, tresenje glave
English: The TREVICTA dose should be based on the previous 1-monthly paliperidone palmitate injectable dose using a 3.5-fold higher dose shown in the following table:
Slovenian: Odmerek zdravila TREVICTA se izračuna glede na zadnji odmerek 1-mesečne injekcije paliperidonijevega palmitata in se pomnoži s faktorjem 3,5, kot je prikazano v spodnji preglednici:
English: From Week 25 onwards Daily dose of paliperidone prolonged release tablets
Slovenian: Dnevni odmerek tablet paliperidona s podaljšanim sproščanjem
English: TREVICTA requires longer and more vigorous shaking than 1-monthly paliperidone palmitate injectable.
Slovenian: Zdravilo TREVICTA je treba stresati dlje in močneje kot 1-mesečne injekcije paliperidonijevega palmitata.
English: Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in patients treated with medicinal products with alpha 1a-adrenergic antagonist effect, such as TREVICTA (see section 4.8).
Slovenian: Pri bolnikih, zdravljenih z zdravili z antagonističnim učinkom na receptorje alfa-1a, kakršno je tudi zdravilo TREVICTA (glejte poglavje 4.8), so med operacijo sive mrene opazili sindrom ohlapne šarenice (Intraoperative Floppy Iris Syndrome, IFIS).
English: For that reason, it is important to discuss with your doctor any of the following conditions which can potentially worsen during treatment with this medicine:
Slovenian: Nekateri neželeni učinki tega zdravila lahko poslabšajo simptome drugih bolezni, zato je pomembno, da se pogovorite z zdravnikom o morebitnih stanjih, ki se lahko poslabšajo med zdravljenjem s tem zdravilom.
English: Consideration should be given to the long-acting nature of the medicinal product and the long elimination half-life of paliperidone when assessing treatment needs and recovery.
Slovenian: Pri oceni potrebe po zdravljenju in bolnikovega okrevanja je treba upoštevati podaljšano sproščanje zdravila in dolg razpolovni čas paliperidona.
English: Pull the needle sheath away from the needle in a straight motion.
Slovenian: Varovalni tulec povlecite z igle povsem naravnost.
English: Population pharmacokinetics analysis showed no evidence of gender related pharmacokinetics differences.
Slovenian: Analiza farmakokinetike populacije ni pokazala razlik v farmakokinetiki zdravila med moškimi in ženskami.
English: Hyperglycaemia, diabetes mellitus, and exacerbation of pre-existing diabetes, including diabetic coma and ketoacidosis, have been reported with paliperidone.
Slovenian: Med zdravljenjem s paliperidonom so poročali o hiperglikemiji, sladkorni bolezni in poslabšanju sladkorne bolezni, vključno z diabetično komo in ketoacidozo.
English: TREVICTA 263 mg injection paliperidone
Slovenian: TREVICTA 263 mg injekcija paliperidon i.m.
English: Each TREVICTA 525 mg pre-filled syringe contains 819 mg paliperidone palmitate.
Slovenian: Ena napolnjena injekcijska brizga zdravila TREVICTA 525 mg vsebuje 819 mg paliperidonijevega palmitata.
English: Cases of venous thromboembolism (VTE) have been reported with antipsychotic medicinal products.
Slovenian: Pri bolnikih, ki so jemali antipsihotike, so poročali o pojavu venskega trombembolizma (VTE).
English: Incomplete administration
Slovenian: Nepopolno injiciranje
English: Thin Wall Safety Needle Selection
Slovenian: Izbira varnostne injekcijske igle s tanko steno
English: At apparent steady-state with TREVICTA, the trough concentrations were similar among normal, overweight, and obese subjects.
Slovenian: Pri uporabi zdravila TREVICTA so bile v navideznem stanju dinamičnega ravnovesja najmanjše koncentracije zdravila približno enake pri normalno težkih, prekomerno težkih in pri debelih preiskovancih.
English: TREVICTA 525 mg injection paliperidone
Slovenian: TREVICTA 525 mg injekcija paliperidon i.m.
English: Each TREVICTA 175 mg pre-filled syringe contains 273 mg paliperidone palmitate.
Slovenian: Ena napolnjena injekcijska brizga zdravila TREVICTA 175 mg vsebuje 273 mg paliperidonijevega palmitata.
English: See also Information intended for medical or healthcare professionals for deltoid injection needle selection based on body weight.
Slovenian: Za izbiro ustrezne igle za injiciranje v deltoidno mišico na osnovi telesne mase glejte tudi Informacije za zdravnike in drugo zdravstveno osebje.
English: • severe allergic reaction characterised by fever, swollen mouth, face, lip or tongue, shortness of breath, itching, skin rash and sometimes drop in blood pressure
Slovenian: obraza, ustnic ali jezika, zasoplost, srbenje, kožni izpuščaj in včasih tudi padec krvnega tlaka
English: Since paliperidone is the major active metabolite of risperidone, caution should be exercised when TREVICTA is co-administered with risperidone or with oral paliperidone for extended periods of time.
Slovenian: Paliperidon je glavni aktivni presnovek risperidona, zato je pri daljši sočasni uporabi zdravila TREVICTA in risperidona ali peroralnega paliperidona potrebna previdnost.
English: Skin and subcutaneous tissue disorders urticaria, pruritus, rash, alopecia, eczema, dry skin, erythema, acne drug eruption, hyperkeratosis, dandruff angioedema, skin discolouration, seborrhoeic dermatitis
Slovenian: Bolezni kože in podkožja urtikarija, srbenje, izpuščaj, alopecija, ekcem, suha koža, eritem, akne medikamentozni izpuščaj, hiperkeratoza, prhljaj angioedem, sprememba barve kože, seboroični dermatitis
English: Each pre-filled syringe contains 819 mg paliperidone palmitate equivalent to 525 mg paliperidone.
Slovenian: Ena napolnjena injekcijska brizga vsebuje 819 mg paliperidonijevega palmitata, kar ustreza 525 mg paliperidona.
English: Reproductive system and breast disorders amenorrhoea, galactorrhoea erectile dysfunction, ejaculation disorder, menstrual disorder e, gynaecomastia, sexual dysfunction, breast pain breast discomfort, breast engorgement, breast enlargement, vaginal discharge priapism
Slovenian: Motnje reprodukcije in dojk amenoreja, galaktoreja erektilna disfunkcija, motnje ejakulacije, motnje menstruacije e, ginekomastija, spolna disfunkcija, bolečine v dojkah neprijeten občutek v dojkah, nabreklost dojk, povečanje dojk, izcedek iz nožnice priapizem
English: Initiate TREVICTA at the following dose
Slovenian: Začetni odmerek zdravila TREVICTA
English: Each TREVICTA 350 mg pre-filled syringe contains 546 mg paliperidone palmitate.
Slovenian: Ena napolnjena injekcijska brizga zdravila TREVICTA 350 mg vsebuje 546 mg paliperidonijevega palmitata.
English: Each TREVICTA 263 mg pre-filled syringe contains 410 mg paliperidone palmitate.
Slovenian: Ena napolnjena injekcijska brizga zdravila TREVICTA 263 mg vsebuje 410 mg paliperidonijevega palmitata.
English: An approximately 3-fold increased risk of cerebrovascular adverse reactions has been seen in randomised placebo-controlled clinical trials in the dementia population with some atypical antipsychotics, including risperidone, aripiprazole, and olanzapine.
Slovenian: V randomiziranih, s placebom nadzorovanih kliničnih preskušanjih populacije z demenco, zdravljene z nekaterimi atipičnimi antipsihotiki, vključno z risperidonom, aripiprazolom in olanzapinom, so opazili približno 3-kratno povečanje tveganja za možganskožilne neželene učinke.
English: TREVICTA is not recommended to treat elderly patients with dementia due to increased risk of overall mortality and cerebrovascular adverse reactions.
Slovenian: Pri starejših bolnikih z demenco zaradi povečanega tveganja za celokupno smrtnost in možganskožilne neželene učinke uporaba zdravila TREVICTA ni priporočljiva.
English: The mean steady-state peak:trough ratio for a TREVICTA dose was 1.6 following gluteal administration and 1.7 following deltoid administration.
Slovenian: Pri zdravilu TREVICTA je bila povprečna vrednost razmerja med največjo in najmanjšo koncentracijo učinkovine v stanju dinamičnega ravnovesja 1,6 po odmerjanju v glutealno mišico in 1,7 po odmerjanju v deltoidno mišico.
English: TREVICTA 175 mg injection paliperidone
Slovenian: TREVICTA 175 mg injekcija paliperidon i.m.
English: General disorders and administration site conditions pyrexia, asthenia, fatigue, injection site reaction face oedema,
Slovenian: Splošne težave in spremembe na mestu aplikacije pireksija, astenija, utrujenost, reakcija na mestu injiciranja edem obraza, edem e,
English: If administering a Deltoid injection
Slovenian: Injiciranje v deltoidno mišico
English: Paliperidone should be used with caution in patients with a pre-existing tumour that may be prolactin-dependent.
Slovenian: Pri bolnikih s tumorji, ki bi lahko bili odvisni od prolaktina, je treba paliperidon uporabljati previdno.
English: TREVICTA has not been studied in patients with hepatic impairment.
Slovenian: Zdravila TREVICTA niso preučevali pri bolnikih z okvaro jeter.
English: Musculoskeletal and connective tissue disorders musculoskeletal pain, back pain, arthralgia blood creatine phosphokinase increased, muscle spasms, joint stiffness, muscular weakness, neck pain rhabdomyolysis, joint swelling posture abnormal
Slovenian: Bolezni mišičnoskeletnega sistema in vezivnega tkiva mišično-skeletna bolečina, bolečine v hrbtu, artralgija povečana koncentracija kreatin kinaze v krvi, mišični krči, otrdelost sklepov, šibkost mišic, bolečine v vratu rabdomioliza, otekanje sklepov nenormalna telesna drža
English: • pneumonia, infection of the chest (bronchitis), infection of the breathing passages, sinus infection, bladder infection, ear infection, tonsillitis, fungal infection of the nails, infection of the skin
Slovenian: (sinusov), okužba sečnega mehurja, okužba ušes, tonzilitis (vnetje mandljev), glivična okužba nohtov, okužba kože
English: Respiratory, thoracic and mediastinal disorders cough, nasal congestion dyspnoea, respiratory tract congestion, wheezing, pharyngolaryngeal pain, epistaxis sleep apnoea syndrome, pulmonary congestion, rales hyperventilation, pneumonia aspiration, dysphonia
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora kašelj, kongestija nosne sluznice dispneja, kongestija dihalnih poti, piskajoče dihanje, faringolaringealna bolečina, epistaksa sindrom apneje v spanju, pljučna kongestija, poki v pljučih hiperventilacija, aspiracijska pljučnica, disfonija
English: • For those < 90 kg, the thin wall 1 inch, 22 gauge (0.72 mm x 25.4 mm) needle should be used.
Slovenian: • pri bolnikih s telesno maso < 90 kg je treba uporabiti iglo s tanko steno, dolžine 1 palec in velikosti 22G (0,72 mm x 25,4 mm).
English: Since paliperidone has been detected in plasma up to 18 months after a single dose administration of TREVICTA, consideration should be given to the long-acting nature of TREVICTA as breastfed infants may be at risk even from TREVICTA administration long before breast-feeding.
Slovenian: Paliperidon so v plazmi lahko izmerili do 18 mesecev po injiciranju enkratnega odmerka zdravila TREVICTA, zato je treba upoštevati podaljšano delovanje zdravila TREVICTA.
English: Each pre-filled syringe contains 273 mg paliperidone palmitate equivalent to 175 mg paliperidone.
Slovenian: Ena napolnjena injekcijska brizga vsebuje 273 mg paliperidonijevega palmitata, kar ustreza 175 mg paliperidona.
English: Hepatobiliary disorders transaminases increased gamma-glutamyltr ansferase increased, hepatic enzyme increased jaundice
Slovenian: Bolezni jeter, žolčnika in žolčevodov povečana koncentracije aminotransferaz povečana koncentracija gama-glutamil transferaze, povečane koncentracije jetrnih encimov zlatenica
English: 263 mg prolonged release suspension for injection
Slovenian: 263 mg suspenzija za injiciranje s podaljšanim sproščanjem
English: Each pre-filled syringe contains 546 mg paliperidone palmitate equivalent to 350 mg paliperidone.
Slovenian: Ena napolnjena injekcijska brizga vsebuje 546 mg paliperidonijevega palmitata, kar ustreza 350 mg paliperidona.
English: TREVICTA 350 mg injection paliperidone
Slovenian: TREVICTA 350 mg injekcija paliperidon i.m.
English: TREVICTA should be used with caution in patients with known cardiovascular disease (e.g., heart failure, myocardial infarction or ischaemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration and hypovolemia).
Slovenian: Pri bolnikih z znano srčnožilno boleznijo (npr. srčnim popuščanjem, miokardnim infarktom ali ishemijo, motnjami prevajanja), možganskožilno boleznijo ali stanji s povečanim tveganjem za hipotenzijo (npr. dehidracija in hipovolemija), je treba zdravilo TREVICTA uporabljati previdno.
English: Doses of paliperidone prolonged release tablets for patients switching from TREVICTA*
Slovenian: Odmerki tablet paliperidona s podaljšanim sproščanjem pri bolnikih, ki so prešli iz zdravila TREVICTA* Število tednov od zadnjega odmerka zdravila TREVICTA
English: First, open needle pouch by peeling the cover back half way.
Slovenian: Najprej do polovice odprite zaščitni omot igle.
English: Initiate 1-monthly paliperidone palmitate injectable 3 months later at the following dose
Slovenian: Začetni odmerek 1-mesečne injekcije paliperidonijevega palmitata (3 mesece po zadnjem odmerku zdravila TREVICTA)
English: Each pre-filled syringe contains 410 mg paliperidone palmitate equivalent to 263 mg paliperidone.
Slovenian: Ena napolnjena injekcijska brizga vsebuje 410 mg paliperidonijevega palmitata, kar ustreza 263 mg paliperidona.
English: Missed dose
Slovenian: Izpuščeni odmerki
English: 350 mg prolonged release suspension for injection
Slovenian: 350 mg suspenzija za injiciranje s podaljšanim sproščanjem
English: Each injection must be administered only by a health care professional giving the full dose in a single injection.
Slovenian: Celoten odmerek je treba dati v eni injekciji.
English: Patients who are adequately treated with 1-monthly paliperidone palmitate injectable (preferably for four months or more) and do not require dose adjustment may be switched to 3-monthly paliperidone palmitate injection.
Slovenian: Na zdravljenje s 3-mesečnimi injekcijami paliperidonijevega palmitata lahko preidejo samo bolniki, ki so ustrezno zdravljeni z 1-mesečnimi injekcijami paliperidonijevega palmitata (če je le možno 4 mesece ali več) in pri katerih prilagajanje odmerka ni potrebno.
English: Gastrointestinal disorders abdominal pain, vomiting, nausea, constipation, diarrhoea, dyspepsia, toothache abdominal discomfort, gastroenteritis, dysphagia, dry mouth, flatulence pancreatitis, swollen tongue, faecal incontinence, faecaloma, cheilitis intestinal obstruction, ileus
Slovenian: Bolezni prebavil bolečina v trebuhu, bruhanje, navzea, obstipacija, driska, dispepsija, zobobol neprijeten občutek v trebuhu, gastroenteritis, disfagija, suha usta, flatulenca pankreatitis, otečen jezik, inkontinenca blata, fekalom, heilitis zapora črevesa, ileus
English: How to store TREVICTA
Slovenian: Shranjevanje zdravila TREVICTA
English: 525 mg prolonged release suspension for injection
Slovenian: 525 mg suspenzija za injiciranje s podaljšanim sproščanjem
English: TREVICTA contains the active substance paliperidone which belongs to the class of antipsychotic medicines and is used as a maintenance treatment for the symptoms of schizophrenia in adult patients.
Slovenian: Zdravilo TREVICTA vsebuje učinkovino paliperidon, ki pripada skupini antipsihotičnih zdravil.
English: • For those ≥ 90 kg, the thin wall 1½ inch, 22 gauge (0.72 mm x 38.1 mm) needle should be used.
Slovenian: • pri bolnikih s telesno maso ≥ 90 kg je treba uporabiti iglo s tanko steno, dolžine 1½ palca in velikosti 22G (0,72 mm x 38,1 mm);
English: • abdominal discomfort, stomach or intestinal infection, difficulty swallowing, dry mouth,
Slovenian: • neprijeten občutek v trebuhu, okužba želodca ali črevesja, oteženo požiranje, suha usta, prekomerno izločanje plinov ali vetrov
English: Common side effects: may affect up to 1 in 10 people
Slovenian: Pogosti neželeni učinki: pojavijo se lahko pri največ 1 od 10 bolnikov
English: • muscle spasms, joint stiffness, muscle weakness, neck pain
Slovenian: • mišični krči, okorelost sklepov, šibkost mišic, bolečine v vratu
English: Population pharmacokinetics analysis showed no evidence of age related pharmacokinetics differences.
Slovenian: Populacijske farmakokinetične analize niso pokazale nobenih razlik v farmakokinetiki zdravila pri uporabi v različnih starostnih skupinah.
English: Rarely, cases of anaphylactic reaction after injection with 1-monthly paliperidone palmitate injectable have been reported during post-marketing experience in patients who have previously tolerated oral risperidone or oral paliperidone (see section 4.4).
Slovenian: V obdobju po prihodu zdravila na trgf so pri bolnikih, ki so dobro prenašali peroralni risperidon ali peroralni paliperidon, poročali o redkih primerih anafilaktične reakcije po aplikaciji 1-mesečne injekcije paliperidonijevega palmitata (glejte poglavje 4.4).
English: Significant weight gain has been reported with TREVICTA use.
Slovenian: Pri uporabi zdravila TREVICTA so poročali o pomembnem povečanju telesne mase.
English: TREVICTA 525 mg prolonged release suspension for injection paliperidone
Slovenian: TREVICTA 525 mg suspenzija za injiciranje s podaljšanim sproščanjem paliperidon
English: Lower Cmax was observed in overweight and obese subjects.
Slovenian: Pri prekomerno težkih in debelih preiskovancih so opažali nižje vrednosti Cmax.
English: TREVICTA 263 mg prolonged release suspension for injection paliperidone
Slovenian: TREVICTA 263 mg suspenzija za injiciranje s podaljšanim sproščanjem paliperidon
English: 175 mg prolonged release suspension for injection
Slovenian: 175 mg suspenzija za injiciranje s podaljšanim sproščanjem
English: Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections
Slovenian: 6.1 Seznam pomožnih snovi polisorbat 20 polietilenglikol 4000 citronska kislina monohidrat natrijev dihidrogenfosfat monohidrat natrijev hidroksid (za uravnavanje pH) voda za injekcije
English: If your baby develops any of these symptoms seek medical attention for your baby.
Slovenian: Če pri otroku opazite kateregakoli od teh simptomov, se posvetujte z zdravnikom.
English: A Kaplan Meier plot of time to relapse by treatment group is shown in Figure 1.
Slovenian: Na sliki 1 je prikazana Kaplan-Meierjeva krivulja časa do relapsa v obeh študijskih skupinah.
English: TREVICTA should be administered within 5 minutes after shaking.
Slovenian: Po stresanju je treba zdravilo TREVICTA bolniku injicirati v 5 minutah.
English: With the syringe tip pointing up, SHAKE VIGOROUSLY with a loose wrist for at least 15 seconds to ensure a homogeneous suspension.
Slovenian: Injekcijsko brizgo obrnite tako, da vrh gleda navzgor in jo najmanj 15 sekund MOČNO STRESAJTE z gibi iz zapestja, da postane suspenzija homogena.